Inovio Pharmaceuticals, Inc. (INO)
1.01
+0.02
(+2.43%)
USD |
NASDAQ |
Oct 15, 10:01
Inovio Pharmaceuticals Total Long Term Debt (Quarterly) : 5.103M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.103M |
| March 31, 2026 | 5.786M |
| December 31, 2025 | 6.545M |
| September 30, 2025 | 7.282M |
| June 30, 2025 | 8.002M |
| March 31, 2025 | 8.695M |
| December 31, 2024 | 9.368M |
| September 30, 2024 | 10.02M |
| June 30, 2024 | 10.66M |
| March 31, 2024 | 11.27M |
| December 31, 2023 | 27.80M |
| September 30, 2023 | 27.68M |
| June 30, 2023 | 28.41M |
| March 31, 2023 | 28.58M |
| December 31, 2022 | 29.27M |
| September 30, 2022 | 29.61M |
| June 30, 2022 | 30.57M |
| March 31, 2022 | 30.97M |
| December 31, 2021 | 30.42M |
| September 30, 2021 | 30.61M |
| June 30, 2021 | 31.33M |
| March 31, 2021 | 31.51M |
| December 31, 2020 | 36.72M |
| September 30, 2020 | 72.36M |
| June 30, 2020 | 98.82M |
| Date | Value |
|---|---|
| March 31, 2020 | 96.39M |
| December 31, 2019 | 97.43M |
| September 30, 2019 | 91.03M |
| June 30, 2019 | 84.24M |
| March 31, 2019 | 82.55M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Nektar Therapeutics | 113.23M |
| Ironwood Pharmaceuticals, Inc. | 393.58M |
| Fortress Biotech, Inc. | 46.07M |
| Tonix Pharmaceuticals Holding Corp. | 1.022M |
| Kura Oncology, Inc. | 23.16M |